Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies.
临床阶段高活性 TcBuster 转座酶的演变,使其成为强大的非病毒过继细胞疗法生产的平台
期刊:Molecular Therapy
影响因子:12
doi:10.1016/j.ymthe.2024.04.024
Skeate Joseph G, Pomeroy Emily J, Slipek Nicholas J, Jones Bryan J, Wick Bryce J, Chang Jae-Woong, Lahr Walker S, Stelljes Erin M, Patrinostro Xiaobai, Barnes Blake, Zarecki Trevor, Krueger Joshua B, Bridge Jacob E, Robbins Gabrielle M, McCormick Madeline D, Leerar John R, Wenzel Kari T, Hornberger Kathlyn M, Walker Kirsti, Smedley Dalton, Largaespada David A, Otto Neil, Webber Beau R, Moriarity Branden S